Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.88
+0.82 (11.54%)
At close: May 12, 2025, 4:00 PM
8.09
+0.21 (2.73%)
After-hours: May 12, 2025, 7:59 PM EDT
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $68.65 million as of May 12, 2025. Its market cap has decreased by -37.70% in one year.
Market Cap
68.65M
Enterprise Value
99.40M
1-Year Change
-37.70%
Ranking
Category
Stock Price
$7.88
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $68.65M, a decrease of -96.36%. That is a compound annual growth rate of -28.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 61.60M | -56.59% |
| Dec 31, 2024 | 141.90M | -21.60% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |